Pityriasis rosea-like adverse reaction: Review of the literature and experience of an Italian drug-surveillance center

Dermatology Online Journal

Volumn 12, Issue 1, 2006, Pages

  Atzori, Laura ^a   Pinna, Anna Luisa ^a   Ferreli, Caterina ^a   Aste, Nicola ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE; LISINOPRIL; NIMESULIDE;

ALGORITHM; ARTICLE; DERMATITIS; DIAGNOSTIC TEST; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DRUG USE; HEALTH PROGRAM; HUMAN; PARAKERATOSIS; PITYRIASIS ROSEA; PRURITUS; TREATMENT WITHDRAWAL; WORLD HEALTH ORGANIZATION;

EID: 32244432130     PISSN: 10872108     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Litt JZ. Pocketbook of drug eruptions and interactions. The Parthenon Publishing Group Inc. New York, 1999 ISBN: 1-85070-077-X.
2. Stulberg DL, Wolfrey JF. Pityriasis rosea. Am Fam Physician 2004; 69:87-92.
3. Wilkin JK, Hammond JJ, Kirkendal WM. The captopril induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol 1980; 116: 902-5.
4. Steckelings UM, Artuc M, Wollschlanger S, Wiehsutz S, Henz BM. Angiotensin-converting enzyme inhibitors as inducers of advers cutaneous reactions. Acta Derm Venereol 2001; 81: 321-5.
5. Wilkin JK, Kirkendall WM. Pityriasis rosea-like rash from captopril. Arch Dermatol 1982; 118: 186-7.
6. Ghersetich I, Rindi L, Teofoli P, Tsampau D, Palleschi GM, Lotti T. Eruzione cutanea da captopril pitiriasi rosea-like. G Ital Dermatol Venereol 1990; 125: 457-9.
7. Atzori L, Ferreli C, Pinna AL, Aste N. Pityriasis rosea-like adverse reaction to lisinopril. J Eur Acad Dermatol Venereol 2004; 18: 743-5.
8. Yosipovitch G, Kuperman O, Livni E, Avinoach I, Halevy S. Pityriasis rosea-like eruption after anti-inflammatory and antipyretic medication. Harefuah 1993; 124: 198-200.
9. Corke CF, Meyrick TR, Huskisson EC, Kirby JD. Pityriasis rosea-like rashes complicating drug therapy for rheumatoid arthritis. Br J Rheumatol 1983; 22: 187-8.
10. Wolf R, Wolf D, Livni E. Pityriasis rosea and ketotifen. Dermatologica 1985; 171: 355-6. 11.
11. Buckley C. Pityriasis rosea-like eruption in a patient receiving omeprazole. Br J Dermatol 1996; 135: 660-1.
12. Helfman RJ, Brickman M, Fahey J. Isotretinoin dermatitis simulating acute pityriasis rosea. Cutis 1984; 33: 297-300.
13. Konstantopoulos K, Papadogianni A, Dimopoulou M, Kourelis C, Meletis J. Pityriasis rosea associated with imatinib. Dermatology 2002; 205: 172-3.
14. Durusoy C, Alpsoy E, Yilmaz E. Pityriasis rosea in a patient with Behcet's disease treated with interferon alpha 2A. J Dermatol 1999;26:225-8.
15. Bonnetblanc JM. Cutaneous reactions to gold salts. Presse Med 1996; 25: 1555-8.
16. Maize JC, Tomecki KJ. Pityriasis rosea-like drug eruption secondary to metronidazole. Arch Dermatol 1977; 113: 1457-8.
17. Sasmaz S, Karabiber H, Boran C, Garipardic M, Balat A. Pityriasis rosea-like eruption due to pneumococcal vaccine in a child with nephrotic syndrome. J Dermatol 2003;30:245-7.
18. De Keyser F, Naeyaert JM, Hindryckx P, Elewaut D, Verplancke P, Peene I, Praet M, Veys E. Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol 2000;18:81-5.
19. Honl BA, Keeling JH, Lewis CW, Thompson IM. A pityriasis rosea-like eruption secondary to bacillus Calmette-Guerin therapy for bladder cancer. Cutis 1996;57:447-50.
20. Kaplan B, Grunwald MH, Halevy S. Pityriasis rosea-like eruption associated with BCG vaccination. Isr J Med Sci 1989;25:570-2.
21. International drug monitoring: the role of national center s. Report of a WHO meeting. World Health Organization Report Series 1972; 498: 1-25.